Katherine Stewart, PharmD, BCOP

AstraZeneca

N/A

Poster(s):

• 1220 - Longitudinal review of cardiac events with acalabrutinib in the treatment of chronic lymphocytic leukemia (CLL) using data from 3 phase 3 randomized controlled trials (RCTs)